نتائج البحث - "Bengt Simonsson"

المساهمون: Hehlmann, R, Cortes, J, Zyczynski, T, Gambacorti-Passerini, C, Goldberg, S, Mauro, M, Michallet, M, Simonsson, B, Williams, L, Gajavelli, S, Degutis, I, Sen, G, Paquette, R

المصدر: American Journal of Hematology

مصطلحات موضوعية: Male, medicine.medical_specialty, Myeloid, medicine.drug_class, Respiratory Tract Diseases, Dasatinib, Antineoplastic Agents, Drug Administration Schedule, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Intolerances, MED/15 - MALATTIE DEL SANGUE, Internal medicine, Humans, Medicine, Molecular Targeted Therapy, Musculoskeletal Diseases, Prospective Studies, Hematologi, Prospective cohort study, Protein Kinase Inhibitors, Research Articles, Aged, Cancer och onkologi, Drug Substitution, business.industry, Disease Management, Myeloid leukemia, Imatinib, Hematology, Hematologic Diseases, United States, respiratory tract diseases, Europe, Pyrimidines, medicine.anatomical_structure, Nilotinib, Drug Resistance, Neoplasm, Cancer and Oncology, 030220 oncology & carcinogenesis, Leukemia, Myeloid, Chronic-Phase, Imatinib Mesylate, Female, business, Research Article, 030215 immunology, medicine.drug

وصف الملف: application/pdf; ELETTRONICO

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf757800bc84051386bb54526e10caf5
https://doi.org/10.1002/ajh.25306

View record at Wiley

5

Epidemiology of Chronic Myeloid Leukaemia

المؤلفون: Martin Höglund, Fredrik Sandin, Bengt Simonsson, Leif Stenke

المصدر: Hematologic Malignancies ISBN: 9783030719128

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e02a3bb241b7ba0a0c9f9c0d077c13a7
https://doi.org/10.1007/978-3-030-71913-5_3

6

Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli

المؤلفون: Angelica Loskog, Satu Mustjoki, Johan Richter, Ulla Olsson-Strömberg, Lisa Christiansson, Stina Söderlund, Inger Persson, Bengt Simonsson, Henrik Hjorth-Hansen

المساهمون: Satu Mustjoki / Principal Investigator, Department of Medicine, Clinicum, Hematologian yksikkö, Department of Oncology

المصدر: Leukemia Research. 50:95-103

مصطلحات موضوعية: Male, Proteomics, 0301 basic medicine, Cancer Research, Myeloid, Angiogenesis, Dasatinib, Tyrosine kinase inhibitor, Pilot Projects, Tyrosine-kinase inhibitor, Th1, DASATINIB THERAPY, 0302 clinical medicine, hemic and lymphatic diseases, Hematology, Neovascularization, Pathologic, Chronic myeloid leukemia, CHRONIC MYELOGENOUS LEUKEMIA, Blood Proteins, Middle Aged, Protein-Tyrosine Kinases, 3. Good health, medicine.anatomical_structure, Oncology, GROWTH-HORMONE DEFICIENCY, 030220 oncology & carcinogenesis, Imatinib Mesylate, Female, Stem cell, STEM-CELLS, medicine.drug, Adult, medicine.medical_specialty, medicine.drug_class, BONE-MARROW, 3122 Cancers, Biology, IMATINIB, 03 medical and health sciences, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, medicine, COMPLETE MOLECULAR REMISSION, Humans, CHRONIC MYELOID-LEUKEMIA, Protein Kinase Inhibitors, Aged, Imatinib, Th1 Cells, medicine.disease, 030104 developmental biology, Immunology, T-CELLS, Cancer research, FOLLOW-UP, Chronic myelogenous leukemia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20d55726b633e372cfff5570ccd0b49f
https://doi.org/10.1016/j.leukres.2016.09.019

View record from ScienceDirect

Full Text via ClinicalKey

7

First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice : SIMPLICITY

المؤلفون: Pascale Cony-Makhoul, Carlo Gambacorti-Passerini, Elza Lomaia, Ruediger Hehlmann, Bengt Simonsson, Michael J. Mauro, Aart Beeker, Mauricette Michallet, Eduardo Olavarria, Stuart L. Goldberg, Richard M. Hansen, Elisabetta Abruzzese, David Andorsky, Aimee Foreman, Jorge E. Cortes, Teresa Zyczynski, H. Jean Khoury, Ron Paquette

المساهمون: Goldberg, S, Cortes, J, Gambacorti-Passerini, C, Hehlmann, R, Khoury, H, Michallet, M, Paquette, R, Simonsson, B, Zyczynski, T, Foreman, A, Abruzzese, E, Andorsky, D, Beeker, A, Cony-Makhoul, P, Hansen, R, Lomaia, E, Olavarria, E, Mauro, M

المصدر: American Journal of Hematology

مصطلحات موضوعية: Oncology, Adult, Male, United State, medicine.medical_specialty, Pediatrics, Myeloid, media_common.quotation_subject, Biopsy, Protein Kinase Inhibitor, Comorbidity, Follow-Up Studie, 03 medical and health sciences, 0302 clinical medicine, Bone Marrow, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Routine clinical practice, Simplicity, Hematologi, Practice Patterns, Physicians', Protein Kinase Inhibitors, Selection (genetic algorithm), Research Articles, In Situ Hybridization, Fluorescence, media_common, Aged, Hematology, business.industry, Myeloid leukemia, Middle Aged, medicine.disease, United States, Europe, Leukemia, medicine.anatomical_structure, Treatment Outcome, 030220 oncology & carcinogenesis, Leukemia, Myeloid, Chronic-Phase, Female, Bone marrow, business, 030215 immunology, Follow-Up Studies, Research Article, Human

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ad2e6a3c4d932c21654f5abea0ec46
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-339738

8

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

المؤلفون: William V. Padula, Richard A. Larson, Stacie B. Dusetzina, Jane F. Apperley, Rudiger Hehlmann, Michele Baccarani, Ekkehard Eigendorff, Joelle Guilhot, Francois Guilhot, Francois-Xavier Mahon, Giovanni Martinelli, Jiri Mayer, Martin C. Müller, Dietger Niederwieser, Susanne Saussele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson, Rena M. Conti

المساهمون: Leuka, National Institute for Health Research, Padula, William V., Larson, Richard A., Dusetzina, Stacie B., Apperley, Jane F., Hehlmann, Rudiger, Baccarani, Michele, Eigendorff, Ekkehard, Guilhot, Joelle, Guilhot, Francoi, Mahon, Francois Xavier, Martinelli, Giovanni, Mayer, Jiri, Müller, Martin C., Niederwieser, Dietger, Saussele, Susanne, Schiffer, Charles A., Silver, Richard T., Simonsson, Bengt, Conti, Rena M.

المصدر: JNCI Journal of the National Cancer Institute

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Medicin och hälsovetenskap, Cost effectiveness, Cost-Benefit Analysis, Medical and Health Sciences, Tyrosine-kinase inhibitor, Antineoplastic Agent, 0302 clinical medicine, Protein-Tyrosine Kinase, Quality-Adjusted Life Year, hemic and lymphatic diseases, Practice Patterns, Physicians', health care economics and organizations, Medicine (all), Myeloid leukemia, Middle Aged, Protein-Tyrosine Kinases, Markov Chains, 3. Good health, Dasatinib, Treatment Outcome, 030220 oncology & carcinogenesis, Imatinib Mesylate, Female, Survival Analysi, Quality-Adjusted Life Years, Models, Econometric, medicine.drug, Human, United State, Adult, medicine.medical_specialty, medicine.drug_class, Protein Kinase Inhibitor, Antineoplastic Agents, Article, 03 medical and health sciences, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, medicine, Drugs, Generic, Humans, Oncology & Carcinogenesis, Cost-Benefit Analysi, neoplasms, Protein Kinase Inhibitors, Aged, business.industry, Imatinib, Markov Chain, medicine.disease, Survival Analysis, United States, 030104 developmental biology, Imatinib mesylate, Nilotinib, Immunology, business, 1112 Oncology And Carcinogenesis, Chronic myelogenous leukemia

وصف الملف: application/pdf; ELETTRONICO

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42698558a7334d55ab20503cad057adb
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-304522

9

Treatment and outcome of 2 904 CML patients from the EUTOS population based registry

المساهمون: Hoffmann, V.S, Baccarani, M., Hasford, J., Castagnetti, F., Di Raimondo, F., Casado, L.F., Turkina, A., Zackova, D., Ossenkoppele, G., Zaritskey, A., Höglund, M., Simonsson, B., Indrak, K., Sninska, Z., Sacha, T., Clark, R., Bogdanovic, A., Hellmann, A., Griskevicius, L., Schubert-Fritschle, G., Sertic, D., Guilhot, J., Lejniece, S., Zupan, I., Burgstaller, S., Koskenvesa, P., Everaus, H., Costeas, P., Lindoerfer, D., Rosti, G., Saussele, S., Hochhaus, A., Hehlmann, R., CCA - Cancer Treatment and quality of life, Hematology

المصدر: Leukemia, 31(3), 593-601. Nature Publishing Group
Hoffmann, V S, Baccarani, M, Hasford, J, Castagnetti, F, Di Raimondo, F, Casado, L F, Turkina, A, Zackova, D, Ossenkoppele, G, Zaritskey, A, Höglund, M, Simonsson, B, Indrak, K, Sninska, Z, Sacha, T, Clark, R, Bogdanovic, A, Hellmann, A, Griskevicius, L, Schubert-Fritschle, G, Sertic, D, Guilhot, J, Lejniece, S, Zupan, I, Burgstaller, S, Koskenvesa, P, Everaus, H, Costeas, P, Lindoerfer, D, Rosti, G, Saussele, S, Hochhaus, A & Hehlmann, R 2017, ' Treatment and outcome of 2904 CML patients from the EUTOS population-based registry ', Leukemia, vol. 31, no. 3, pp. 593-601 . https://doi.org/10.1038/leu.2016.246

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Cancer Research, Adolescent, Population, 03 medical and health sciences, European LeukemiaNet, Young Adult, 0302 clinical medicine, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Registries, education, Survival analysis, Aged, Aged, 80 and over, education.field_of_study, business.industry, Incidence (epidemiology), Incidence, Imatinib, Hematology, Middle Aged, Survival Analysis, 3. Good health, Surgery, Dasatinib, Clinical trial, Europe, Treatment Outcome, Anesthesiology and Pain Medicine, Oncology, Nilotinib, 030220 oncology & carcinogenesis, Population Surveillance, Female, business, 030215 immunology, medicine.drug, Follow-Up Studies

وصف الملف: STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187685d518aa1801d232adea9a7163ab
http://hdl.handle.net/20.500.11769/45823

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

10

Epidemiology of Chronic Myeloid Leukemia

المؤلفون: Fredrik Sandin, Bengt Simonsson, Martin Höglund

المصدر: Hematologic Malignancies ISBN: 9783319331973

مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, Relative survival, business.industry, Incidence (epidemiology), Population, Myeloid leukemia, Clinical trial, hemic and lymphatic diseases, Internal medicine, Epidemiology, medicine, In patient, education, business, Socioeconomic status

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bdcbbec2ba22dc30e3396e61b3461b59
https://doi.org/10.1007/978-3-319-33198-0_7

تنقيح النتائج